About this event

  • Date and time Thu 8 Apr 2021 from 6:00pm to 7:30pm
  • Location Online
  • Organised by Medicine and Me, Action for Pulmonary Fibrosis

Jointly organised with Action for Pulmonary Fibrosis, this meeting will give you an understanding of what it is like to live with Idiopathic Pulmonary Fibrosis (IPF) from people living with the disease.

Pulmonary fibrosis (PF) is thought to affect around 70,000 people in the UK. One of the most aggressive and common forms of PF is Idiopathic Pulmonary Fibrosis (IPF). Idiopathic means it has no known cause. IPF normally affects people over 50 and is slightly more common in men than women. There are limited treatments and there is no cure. Life expectancy can be between three to five years following diagnosis, and around 6,000 people die from it every year in the UK.

In this webinar, we will discuss the current approaches to diagnosis, active treatment and symptom management of IPF from the perspective of patients and their carers. We will also explore the latest cutting edge research, as we consider areas of inquiry likely to deliver step changes in treatment. 

CPD accredited: A CPD certificate with 1 CPD credit will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording. 

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed 

About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management. Physicians, surgeons and indeed all healthcare professionals, continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

We would like to thank our anonymous donor for their generous support enabling this platform for patient focused charities and free access to the Medicine and Me series.

Key speakers

Dr Helen Parfrey

Dr Helen Parfrey

Consultant Respiratory Physician, Royal Papworth Hospital

Speaker's biography

Dr Helen Parfrey is a consultant Respiratory Physician at the Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital and lead for East Anglia ILD Network.


She completed her medical training at the University of Oxford and obtained her PhD at the University of Cambridge. She was a Wellcome Trust Fellow at National Jewish Hospital in Denver, Colorado.


She is a visiting senior research fellow at the University of Cambridge and has clinical and translational research interests in the role of the innate immune response in pulmonary fibrosis and RA-ILD. She is also a founding trustee for Action for Pulmonary Fibrosis.

Dr Philip Molyneaux

Dr Philip Molyneaux

Consultant Respiratory Physician, Royal Brompton Hospital and Senior Clinical Lecturer in Interstitial lung disease, Imperial College London


View the programme

Welcome and introduction

Steve Jones, Chair of Trustees, Action for Pulmonary Fibrosis, and Prof Humphrey Scott, Dean, The Royal Society of Medicine 

Pulmonary fibrosis – diagnosis, treatment and symptom management

Dr Helen Parfrey, Royal Papworth Hospital, University of Cambridge

Question and answers
Cutting edge research – where will we be in 2030?

Dr Philip Molyneaux, Royal Brompton Hospital, Imperial College, London

Question and answers
Panel discussion

Chair: Steve Jones, Chair of Trustees, Action for Pulmonary Fibrosis 

Closing comments
Close of meeting



Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member